Abstract
Buparvaquone is leishmaniose drug which has a limited solubility in water. Its confinement and transport in lipidic nanoparticles has already been investigated. A new strategy is being proposed based on its complexation with iron(III) ions or immobilization in superparamagnetic nanoparticles.